These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15728923)

  • 1. A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycin-resistant Enterococcus faecalis.
    Qiu XQ; Zhang J; Wang H; Wu GY
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1184-9. PubMed ID: 15728923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VanG-type vancomycin-resistant Enterococcus faecalis strains isolated in Canada.
    Boyd DA; Du T; Hizon R; Kaplen B; Murphy T; Tyler S; Brown S; Jamieson F; Weiss K; Mulvey MR
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2217-21. PubMed ID: 16723588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial effect of butyryl alkannin from Arnebia euchroma against vancomycin-resistant pathogens of Enterococcus faecalis causing urinary tract infections.
    Singh LK; Maheshwari DK; Shukla S
    Nat Prod Res; 2015; 29(24):2299-301. PubMed ID: 25635653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nosocomial infection caused by vancomycin-susceptible multidrug-resistant Enterococcus faecalis over a long period in a university hospital in Japan.
    Kudo M; Nomura T; Yomoda S; Tanimoto K; Tomita H
    Microbiol Immunol; 2014 Nov; 58(11):607-14. PubMed ID: 25145983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of fungicidal peptide dhvar4 to enterococcal peptide pheromone increases its bactericidal activity against Enterococcus faecalis.
    Lu X; Wan L; Yang H; Zhang J; Li S; Kang M; Li Y; Cheng J
    Chem Biol Drug Des; 2006 Oct; 68(4):220-4. PubMed ID: 17105486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An engineered multidomain bactericidal peptide as a model for targeted antibiotics against specific bacteria.
    Qiu XQ; Wang H; Lu XF; Zhang J; Li SF; Cheng G; Wan L; Yang L; Zuo JY; Zhou YQ; Wang HY; Cheng X; Zhang SH; Ou ZR; Zhong ZC; Cheng JQ; Li YP; Wu GY
    Nat Biotechnol; 2003 Dec; 21(12):1480-5. PubMed ID: 14625561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.
    Tang HJ; Chen CC; Zhang CC; Su BA; Li CM; Weng TC; Chiang SR; Ko WC; Chuang YC
    Diagn Microbiol Infect Dis; 2013 Nov; 77(3):254-7. PubMed ID: 24029433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations.
    Tsuji BT; Bulitta JB; Brown T; Forrest A; Kelchlin PA; Holden PN; Peloquin CA; Skerlos L; Hanna D
    J Antimicrob Chemother; 2012 Sep; 67(9):2182-90. PubMed ID: 22685161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of clones and genotypes among vancomycin-resistant clinical Enterococcus isolates recovered in a Spanish hospital.
    López M; Cercenado E; Tenorio C; Ruiz-Larrea F; Torres C
    Microb Drug Resist; 2012 Oct; 18(5):484-91. PubMed ID: 22694211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antibacterial activity of the peptide PsVP-10 against antimicrobial-resistant Enterococcus faecalis isolated from clinical samples.
    Padilla C; Lobos O; Brevis P; Abaca P; Hubert E
    J Antimicrob Chemother; 2004 Feb; 53(2):390-2. PubMed ID: 14729763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of a subinhibitory concentration of vancomycin on the in vitro expression of virulence-related genes in the vancomycin-resistant Enterococcus faecalis.
    Moura TM; Campos FS; Caierão J; Franco AC; Roehe PM; d'Azevedo PA; Frazzon J; Frazzon AP
    Rev Soc Bras Med Trop; 2015; 48(5):617-21. PubMed ID: 26516976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
    Cunha BA; Mickail N; Eisenstein L
    Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of vancomycin susceptibility in Enterococcus faecalis by antiresistance determinant gene transfer.
    Torres Viera C; Tsiodras S; Gold HS; Coakley EP; Wennersten C; Eliopoulos GM; Moellering RC; Inouye RT
    Antimicrob Agents Chemother; 2001 Mar; 45(3):973-5. PubMed ID: 11181395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China.
    Sun H; Wang H; Xu Y; Jones RN; Costello AJ; Liu Y; Li G; Chen M; Mendes RE
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):399-403. PubMed ID: 23099304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis.
    Biavasco F; Miele A; Vignaroli C; Manso E; Lupidi R; Varaldo PE
    Microb Drug Resist; 1996; 2(2):231-7. PubMed ID: 9158765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE).
    Jia Y; Bois-Choussy M; Malabarba A; Brunati C; Zhu J
    J Antibiot (Tokyo); 2006 Sep; 59(9):543-52. PubMed ID: 17136887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outbreak of vancomycin-resistant enterococci in a tertiary hospital: the lack of effect of measures directed mainly by surveillance cultures and differences in response between Enterococcus faecium and Enterococcus faecalis.
    Pereira GH; Müller PR; Zanella RC; de Jesus Castro Lima M; Torchio DS; Levin AS
    Am J Infect Control; 2010 Jun; 38(5):406-9. PubMed ID: 20006408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.